Breast Biopsy Market 2019 Global Industry Size, Future Trends, Regional Analysis, Segmentation, Application, Technology, Leading Players & Future Forecast by 2023

Breast Biopsy Market 2019 Global Industry Size, Future Trends, Regional Analysis, Segmentation, Application, Technology, Leading Players & Future Forecast by 2023

“Breast Biopsy Market”
This 2019 Outlook Reviews The Current State Of The Global Health Care Sector And Explores Trends And Issues Impacting Health Care Providers, Governments, Payers, Patients, And Other Stakeholders. It Also Outlines Suggestions For Them As They Seek To Redefine The Health Care Ecosystem And Looks At Examples From The Market. A Breast Biopsy Is The Removal Of A Sample Of Breast Tissue So That It Can Be Tested For Breast Cancer. This Can Be Done In A Few Ways. With A Core Needle Biops This Innovation Will Help In Health


A biopsy is a small operation that is used to perform the removal of tissues from an area of concern from the body. Breast biopsy is a medical procedure that involves the testing of small samples of breast tissues for the detection of breast cancer. This form of biopsy is conducted with the help of minimally invasive biopsy systems due to minimal pain and disfigurement.

There are various types of biopsy procedures that are used depending upon the different techniques like vacuum-assisted biopsy (VAB), core needle biopsy (CNB), and fine needle aspiration biopsy (FNAB). These are recommended by the doctor based on the size, location, and other characteristics of the breast abnormality. The global breast biopsy market is expected to expand in significant fashion during the forecast period of 2018 to 2023.

The increasing prevalence of breast cancer, especially for women above 35 years of age during menopause, who are more susceptible to breast cancer, and rising awareness concerning breast cancer screening programs are the major drivers of the market. However, there are various constraints limiting the market growth as well.

This includes the infection risks associated with breast biopsy procedures, unspecified regulatory issues, and ambiguous reimbursement policies. In addition to these, the market growth is also restricted due to the high cost of surgical procedures and the risks associated with them. At the same time, the emergence of technologically-advanced and the usage of breast biopsy devices that are minimally invasive are expected to tap into the potential opportunities that the market holds.

Competitive Analysis

The main players in the breast biopsy market globally are C.R. Bard Inc., NuVue Therapeutics, Argon Medical Devices, Inc., Devicor Medical Products Inc. Hologic Inc. Argon Medical Devices, Cook Medical Incorporated, Leica Biosystems, Encapsule Medical Devices LLC., Johnson & Johnson, Intact Medical Corporation, Becton, Dickinson and Company, Conceptus INC, Hologic Inc., Galini SRL, Karl Storz GmbH & Co. Kg, GE Healthcare.

Significant reductions in administrative costs are inducing further expansion of the market. The vertical additions and product tactics of the market are boosting the potential of the market players. The development of a robust value chain is further motivating the development of the market. The strategic goals intended for the market are reinforced due to favorable product differentiation carried out by market competitors.

 Fill Out Details To Receive FREE Sample Here:

The growth of the market is moving in a favorable direction due to new product launches or rising gross revenue of the players in the market. Increased adaptability of market players to new market trends and customers inclinations are lifting the growth curve of the market and will continue do so in the forecast period. The successful implementation of strategies is expected to motivate the market in the coming years.

Segmental Analysis

The breast biopsy market has been carried out on the basis of guidance technology, technique type, product, and end-user. Based on product, the breast biopsy market has been segmented into biopsy tables, guidance systems, biopsy needles, biopsy wires, and others. The segmentation on the basis of technique type, the market is segmented into core needle biopsy, biopsy markers, fine needle aspiration biopsy, surgical biopsy, MRI-guided core needle biopsy, wire localization, and sentinel node biopsy. Additionally, the core needle biopsy segment is segmented into vacuum-assisted biopsy, ultrasound-guided core biopsy, stereotactic core needle biopsy, and freehand core-needle biopsy.

The surgical biopsy is divided into excisional biopsy and incisional biopsy. Based on guidance technology, the breast biopsy market is segmented into mammography-guided magnetic resonance, CT-guided biopsy, ultrasound-guided, and other image-guided breast biopsy (thermography and PET). The end-user based segmentation of the market consists of ambulatory surgical centers, hospitals, diagnostic centers, among others. The regions that are a part of the breast biopsy market are Europe, Asia Pacific, Americas, and the Middle East and Africa.

Detailed Regional Analysis

The regional analysis of the breast biopsy market observes that the North American region is projected to account for the principal market share owing to the early implementation of sophisticated medical technologies and constant development by companies working in cancer diagnostics. The breast biopsy market is mainly focused on the North American and European regions, which is expected to account for more than 50% of the market portion.

The European market is estimated to hold the next biggest market share as breast cancer is found to be most common in countries such as the UK and Belgium. The market share in the Asia Pacific region is also estimated to experience growth in the near future due to access to optimal treatment facilities, better adoption rate, growing demand for advanced technology, growing government initiatives, and rising healthcare costs. The market in the Middle Eastern and African region is projected to be responsible for the smallest share of the breast biopsy market owing to deficiency of technical knowledge, an underdeveloped healthcare sector, and meager medical facilities.

Global Breast Biopsy Market, by Guidance Technology

  • Fine ultrasound-guided
  • Mammography-guided magnetic resonance
  • CT-guided biopsy
  • Other image-guided breast biopsy (PET and thermography)

Global Breast Biopsy Market, by End-User

  • Hospitals
  • Ambulatory surgical centers
  • Diagnostic centers
  • Other


Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

5.1.5 Intensity Of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Breast Biopsy Market, By Product

6.1 Introduction

6.2 Biopsy Needles

6.3 Biopsy Tables

6.4 Biopsy Wires

6.5 Guidance Systems

6.6 Others

Chapter 7. Global Breast Biopsy Market, By Technique Type

7.1 Introduction

7.2 Fine Needle Aspiration Biopsy

7.3 Core Needle Biopsy

7.3.1 Stereotactic Core Needle Biopsy

7.3.2 Vacuum Assisted Biopsies

7.3.3 Ultrasound Guided Core Biopsy

7.3.4 Freehand Needle Biopsy

7.4 Biopsy Markers

7.5 MRI-Guided Core Needle Biopsy

7.6 Surgical Biopsy

7.6.1 Incisional Biopsy

7.6.2 Excisional Biopsy

7.7 Wire Localization

7.8 Sentinel Node Biopsy

Chapter 8. Global Breast Biopsy Market, By Guidance Technology

8.1 Introduction

8.2 Fine Ultrasound-Guided

8.3 Mammography-Guided Magnetic Resonance

8.4 CT-Guided Biopsy

8.5 Other Image-Guided Breast Biopsy (PET And Thermography)

Chapter 9 Global Breast Biopsy Market, By End-User

9.1 Introduction

9.2 Hospitals

9.3 Ambulatory Surgical Centers

9.4 Diagnostic Centers

9.5 Other

Chapter 10. Global Breast Biopsy Market, By Region

10.1 Introduction

10.2 America

10.2.1 North America US Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe Germany France Italy Spain UK Rest Of Western Europe

10.3.2 Eastern Europe

10.4 Asia-Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 Republic Of Korea

10.4.6 Rest Of Asia-Pacific

10.5 Middle East & Africa

10.5.1 United Arab Emirates

10.5.2 Saudi Arabia

10.5.3 Oman

10.5.4 Kuwait

10.5.5 Qatar

10.5.6 Rest Of The Middle East & Africa

Chapter 11. Company Landscape


Get Breast Biopsy Market spread across 100 Premium Pages, Top 10 Companies and Supported with Tables and 57 Figures is Now Available:

 About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India